Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li, Jiajing Wu, Jianhui Nie, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1284-1294.e9
Open Access | Times Cited: 1553

Showing 26-50 of 1553 citing articles:

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 648-654
Open Access | Times Cited: 441
Structural impact on SARS-CoV-2 spike protein by D614G substitution
Jun Zhang, Yongfei Cai, Tianshu Xiao, et al.
Science (2021) Vol. 372, Iss. 6541, pp. 525-530
Open Access | Times Cited: 430
Wearable materials with embedded synthetic biology sensors for biomolecule detection
Peter Q. Nguyen, Luis R. Soenksen, Nina M. Donghia, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 11, pp. 1366-1374
Open Access | Times Cited: 410
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan, Qianqian Zheng, Hongxia Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 408
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Jianhui Nie, Qianqian Li, Jiajing Wu, et al.
Nature Protocols (2020) Vol. 15, Iss. 11, pp. 3699-3715
Open Access | Times Cited: 392
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li, Jianhui Nie, Jiajing Wu, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2362-2371.e9
Open Access | Times Cited: 382
SARS-CoV-2 within-host diversity and transmission
Katrina Lythgoe, Matthew Hall, Luca Ferretti, et al.
Science (2021) Vol. 372, Iss. 6539
Open Access | Times Cited: 380
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 378
Emergence of a Novel SARS-CoV-2 Variant in Southern California
Wenjuan Zhang, Brian Davis, Stephanie S. Chen, et al.
JAMA (2021) Vol. 325, Iss. 13, pp. 1324-1324
Open Access | Times Cited: 373
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 373
SARS-CoV-2 variants of concern are emerging in India
Jasdeep Singh, Syed Asad Rahman, Nasreen Z. Ehtesham, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1131-1133
Closed Access | Times Cited: 371
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 6, pp. 867-879.e5
Open Access | Times Cited: 370
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 360
The emergence, genomic diversity and global spread of SARS-CoV-2
Juan Li, Shengjie Lai, George F. Gao, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 408-418
Open Access | Times Cited: 354
T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 353
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244126-e0244126
Open Access | Times Cited: 345
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Rafał Butowt, Christopher S. von Bartheld
The Neuroscientist (2020) Vol. 27, Iss. 6, pp. 582-603
Open Access | Times Cited: 329
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
S. Gobeil, Katarzyna Janowska, Shana McDowell, et al.
Cell Reports (2020) Vol. 34, Iss. 2, pp. 108630-108630
Open Access | Times Cited: 327
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
Vincent Legros, Solène Denolly, Manon Vogrig, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 2, pp. 318-327
Open Access | Times Cited: 324
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 318
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
Jinhui Dong, Seth J. Zost, Allison J. Greaney, et al.
Nature Microbiology (2021) Vol. 6, Iss. 10, pp. 1233-1244
Open Access | Times Cited: 310
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
Lucy van Dorp, Damien Richard, Cedric C.S. Tan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 306
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 304
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 282
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Cheol-Min Kim, Dong-Kyun Ryu, Jihun Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 277

Scroll to top